MYLAN
VTRSViatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Drugs in Pipeline
92
Phase 3 Programs
79
Upcoming Catalysts
5
Next Catalyst
Oct 17, 2026
28dMarket Overview
Stock performance and key metrics
6 upcoming, 0 past
How VTRS's past catalysts played out
iv sildenafil
Pulmonary Hypertension, Familial Persistent, of the Newborn
MYL-1601D Product
Diabetes Mellitus, Type 1
venlafaxine ER 75 mg/day (fixed dose)
Major Depressive Disorder
LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION
Glaucoma, Primary Open Angle (POAG)
Revefenacin
Chronic Obstructive Pulmonary Disease, COPD
Econazole Nitrate Cream, 1%
Tinea Pedis
Eletriptan 20 mg
Migraine With or Without Aura
Eletriptan 80 mg
Migraine With or Without Aura
cholecalciferol 200,000 IU
Coronavirus
ziprasidone versus olanzapine , risperidone or quetiapine
Schizophrenia
Sildenafil citrate
Pulmonary Arterial Hypertension, Children
olanzapine
Schizophrenia
sildenafil citrate (UK-92,480)
Pulmonary Hypertension
celecoxib and ibuprofen SR
Pain, Postoperative
MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
Asthma
Tramadol
Acute Pain
sildenafil
Sexual Dysfunctions, Psychological
Pregabalin Dose Level 1
Generalized Tonic Clonic Seizures
Pregabalin Dose Level 2
Partial Onset Seizures
Loxoprofen
Low Back Pain
Pregabalin add-on therapy
Epilepsy, Partial Seizures
pramipexole
Restless Legs Syndrome
Diclofenac sodium gel 1%
Osteoarthritis, Knee
tolterodine extended release capsule
Urinary Incontinence
MR-107A-02
Acute Pain
Venlafaxine ER
Major Depressive Disorder
Venlafaxine XR
Anxiety
Xalacom
Glaucoma, Open Angle
Mylan's insulin glargine
Type 1 Diabetes
Lantus®
Type 2 Diabetes
MYL-1701P, a proposed biosimilar to Eylea
Diabetic Macular Edema
Pimecrolimus Cream, 1%
Atopic Dermatitis
Ziprasidone
Schizophrenia
Transdermal system containing progestin
Female Contraception
MYL-1501D product using manufacture process V
Diabetes Mellitus, Type 1
Eletriptan HBr 40 mg
Migraine Without Aura
Eplerenone
Heart Failure
Geodon (Ziprasidone)
Bipolar Disorder
Xalatan
Glaucoma, Open-Angle
Diphenhydramine citrate
Healthy
Indomethacin
Arthritis, Gouty
Atorvastatin calcium 10 mg
Hypercholesterolemia
Ziprasidone Oral Capsule
Bipolar Mania
Intramuscular ziprasidone mesylate
Schizophrenia
Nebivolol
Hypertension
Revefenacin 175 mcg in 3 ML Inhalation Solution
COPD
Timolol
Open Angle Glaucoma
Amlodipine/Atorvastatin
Hypertension
Clozapine
Schizophrenia
Estradiol Vaginal Cream, 0.01%
Atrophic Vaginitis
Eletriptan 40 mg
Migraine With or Without Aura
Nebivolol and Atenolol
Hypertension
TD-4208
Chronic Obstructive Pulmonary Disease (COPD)
Amlodipine 2.5mg/Atorvastatin 5mg
Hypertension
latanoprost 0.005%
Ocular Hypertension
Lamotrigine
Epilepsy, Partial
Ziprasidone oral capsules
Bipolar Disorder
PhXA41
Open Angle Glaucoma
Tiotropium
Chronic Obstructive Pulmonary Disease (COPD)
MR-100A-01
Contraception
Nebivolol (NEB)
Hypertension
levetiracetam
Partial Seizures
i. Fixed combination of latanoprost 0.005% and timolol 0.5%
Ocular Hypertension
MYL-1401H
Breast Neoplasms
latanoprost
Glaucoma
Formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Diclofenac SR
Ankylosing Spondylitis
pramipexol
Idiopathic Restless Legs Syndrome
Sumatriptan 25 mg
Migraine With or Without Aura
MYL- 1401O
Breast Cancer
MYL-1701P
Diabetic Macular Edema
Gabapentin
Transient Insomnia
apomorphine HCl injection
Parkinson Disease
Amlodipine
Hypertension
Amlodipine/atorvastatin single pill
Hypertension
pregabalin
Neuralgia
celecoxib
Low Back Pain
MYL-1401A (Adalimumab)
Psoriasis
pregabalin (Lyrica)
Pain, Postoperative
TD-4208 700 μg
Chronic Obstructive Pulmonary Disease, COPD
MR-107A-01
Pain
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)
Contraception
Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
HIV-associated Tuberculosis
Sildenafil 100 mg
Female Sexual Arousal Disorder
MR-130A-01 Transdermal patch
Contraception
latanoprost 75 ug
Primary Open Angle Glaucoma
generic FDC of TDF/3TC/EFV
HIV
Cysteamine
HIV Infections
Revefenacin Inhalation Solution [Yupelri]
COPD
Alprazolam
Dental Anxiety
sertraline/[S,S]-reboxetine
Depressive Disorder, Major
Permethrin Foam 4%
Scabies
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
iv sildenafil | Phase 3 | Pulmonary Hypertension, Familial Persistent, of the Newborn | - | - |
MYL-1601D Product | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
venlafaxine ER 75 mg/day (fixed dose) | Phase 3 | Major Depressive Disorder | - | - |
LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION | Phase 3 | Glaucoma, Primary Open Angle (POAG) | - | - |
Revefenacin | Phase 3 | Chronic Obstructive Pulmonary Disease, COPD | - | - |
Econazole Nitrate Cream, 1% | Phase 3 | Tinea Pedis | - | - |
Eletriptan 20 mg | Phase 3 | Migraine With or Without Aura | - | - |
Eletriptan 80 mg | Phase 3 | Migraine With or Without Aura | - | - |
cholecalciferol 200,000 IU | Phase 3 | Coronavirus | - | - |
ziprasidone versus olanzapine , risperidone or quetiapine | Phase 3 | Schizophrenia | - | - |
Sildenafil citrate | Phase 3 | Pulmonary Arterial Hypertension, Children | - | - |
olanzapine | Phase 3 | Schizophrenia | - | - |
sildenafil citrate (UK-92,480) | Phase 3 | Pulmonary Hypertension | - | - |
celecoxib and ibuprofen SR | Phase 3 | Pain, Postoperative | - | - |
MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate) | Phase 3 | Asthma | - | - |
Tramadol | Phase 3 | Acute Pain | - | - |
sildenafil | Phase 3 | Sexual Dysfunctions, Psychological | - | - |
Pregabalin Dose Level 1 | Phase 3 | Generalized Tonic Clonic Seizures | - | - |
Pregabalin Dose Level 2 | Phase 3 | Partial Onset Seizures | - | - |
Loxoprofen | Phase 3 | Low Back Pain | - | - |
Pregabalin add-on therapy | Phase 3 | Epilepsy, Partial Seizures | - | - |
pramipexole | Phase 3 | Restless Legs Syndrome | - | - |
Diclofenac sodium gel 1% | Phase 3 | Osteoarthritis, Knee | - | - |
tolterodine extended release capsule | Phase 3 | Urinary Incontinence | - | - |
MR-107A-02 | Phase 3 | Acute Pain | - | - |
Venlafaxine ER | Phase 3 | Major Depressive Disorder | - | - |
Venlafaxine XR | Phase 3 | Anxiety | - | - |
Xalacom | Phase 3 | Glaucoma, Open Angle | - | - |
Mylan's insulin glargine | Phase 3 | Type 1 Diabetes | - | - |
Lantus® | Phase 3 | Type 2 Diabetes | - | - |
MYL-1701P, a proposed biosimilar to Eylea | Phase 3 | Diabetic Macular Edema | - | - |
Pimecrolimus Cream, 1% | Phase 3 | Atopic Dermatitis | - | - |
Ziprasidone | Phase 3 | Schizophrenia | - | - |
Transdermal system containing progestin | Phase 3 | Female Contraception | - | - |
MYL-1501D product using manufacture process V | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
Eletriptan HBr 40 mg | Phase 3 | Migraine Without Aura | - | - |
Eplerenone | Phase 3 | Heart Failure | - | - |
Geodon (Ziprasidone) | Phase 3 | Bipolar Disorder | - | - |
Xalatan | Phase 3 | Glaucoma, Open-Angle | - | - |
Diphenhydramine citrate | Phase 3 | Healthy | - | - |
Indomethacin | Phase 3 | Arthritis, Gouty | - | - |
Atorvastatin calcium 10 mg | Phase 3 | Hypercholesterolemia | - | - |
Ziprasidone Oral Capsule | Phase 3 | Bipolar Mania | - | - |
Intramuscular ziprasidone mesylate | Phase 3 | Schizophrenia | - | - |
Nebivolol | Phase 3 | Hypertension | - | - |
Revefenacin 175 mcg in 3 ML Inhalation Solution | Phase 3 | COPD | - | - |
Timolol | Phase 3 | Open Angle Glaucoma | - | - |
Amlodipine/Atorvastatin | Phase 3 | Hypertension | - | - |
Clozapine | Phase 3 | Schizophrenia | - | - |
Estradiol Vaginal Cream, 0.01% | Phase 3 | Atrophic Vaginitis | - | - |
Eletriptan 40 mg | Phase 3 | Migraine With or Without Aura | - | - |
Nebivolol and Atenolol | Phase 3 | Hypertension | - | - |
TD-4208 | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Amlodipine 2.5mg/Atorvastatin 5mg | Phase 3 | Hypertension | - | - |
latanoprost 0.005% | Phase 3 | Ocular Hypertension | - | - |
Lamotrigine | Phase 3 | Epilepsy, Partial | - | - |
Ziprasidone oral capsules | Phase 3 | Bipolar Disorder | - | - |
PhXA41 | Phase 3 | Open Angle Glaucoma | - | - |
Tiotropium | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
MR-100A-01 | Phase 3 | Contraception | - | - |
Nebivolol (NEB) | Phase 3 | Hypertension | - | - |
levetiracetam | Phase 3 | Partial Seizures | - | - |
i. Fixed combination of latanoprost 0.005% and timolol 0.5% | Phase 3 | Ocular Hypertension | - | - |
MYL-1401H | Phase 3 | Breast Neoplasms | - | - |
latanoprost | Phase 3 | Glaucoma | - | - |
Formoterol | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Diclofenac SR | Phase 3 | Ankylosing Spondylitis | - | - |
pramipexol | Phase 3 | Idiopathic Restless Legs Syndrome | - | - |
Sumatriptan 25 mg | Phase 3 | Migraine With or Without Aura | - | - |
MYL- 1401O | Phase 3 | Breast Cancer | - | - |
MYL-1701P | Phase 3 | Diabetic Macular Edema | - | - |
Gabapentin | Phase 3 | Transient Insomnia | - | - |
apomorphine HCl injection | Phase 3 | Parkinson Disease | - | - |
Amlodipine | Phase 3 | Hypertension | - | - |
Amlodipine/atorvastatin single pill | Phase 3 | Hypertension | - | - |
pregabalin | Phase 3 | Neuralgia | - | - |
celecoxib | Phase 3 | Low Back Pain | - | - |
MYL-1401A (Adalimumab) | Phase 3 | Psoriasis | - | - |
pregabalin (Lyrica) | Phase 3 | Pain, Postoperative | - | - |
TD-4208 700 μg | Phase 2 | Chronic Obstructive Pulmonary Disease, COPD | - | - |
MR-107A-01 | Phase 2 | Pain | - | - |
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN) | Phase 2 | Contraception | - | - |
Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC | Phase 2 | HIV-associated Tuberculosis | - | - |
Sildenafil 100 mg | Phase 2 | Female Sexual Arousal Disorder | - | - |
MR-130A-01 Transdermal patch | Phase 2 | Contraception | - | - |
latanoprost 75 ug | Phase 2 | Primary Open Angle Glaucoma | - | - |
generic FDC of TDF/3TC/EFV | Phase 2 | HIV | - | - |
Cysteamine | Phase 2 | HIV Infections | - | - |
Revefenacin Inhalation Solution [Yupelri] | Phase 2 | COPD | - | - |
Alprazolam | Phase 2 | Dental Anxiety | - | - |
sertraline/[S,S]-reboxetine | Phase 2 | Depressive Disorder, Major | - | - |
Permethrin Foam 4% | Phase 2 | Scabies | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in MYLAN's drug pipeline?→
CatalystAlert tracks 92 drug candidates in MYLAN's (VTRS) pipeline across Phase 3, Phase 2. Its lead program is iv sildenafil (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MYLAN's next FDA catalyst?→
MYLAN's (VTRS) next tracked catalyst is a NDA Filing expected October 17, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VTRS biotech catalysts?→
Add VTRS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MYLAN's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.